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Abstract
Since 2003, outbreaks of lymphogranuloma venereum (LGV)
have been reported in European countries, North America, and
Australia. Current LGV cases have been caused by Chlamydia tra-
chomatis serovar L2. This sexually transmitted infection is pre-
dominantly found among men who have sex with men,
speciﬁcally men who are seropositive for human immunodeﬁ-
ciency virus and have clinical signs of proctitis. The current out-
break has been almost exclusively attributed to a new variant,
designated L2b. Although urogenital cases of LGV have been
described in the heterosexual population, we report the ﬁrst
case of C. trachomatis L2b proctitis in a woman.
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Since 2003, a lymphogranuloma venereum (LGV) Chlamydia
trachomatis proctitis outbreak caused by the new variant L2b
has been reported in industrialized countries in men who
have had sex with human immunodeﬁciency virus (HIV)-posi-
tive men [1,2]. We report the ﬁrst case of C. trachomatis L2b
proctitis diagnosed in a woman without other sexually trans-
mitted infections (STIs).
In February 2009, a 44-year-old woman presented with
gastrointestinal symptoms, such as frequent urge to have a
bowel movement, difﬁculties with continence, and general-
ized weakness. In April 2009, she arrived for a consultation
at the gastroenterology department at Robert Boulin Hospi-
tal (Libourne, France) with complaints of anorectal pain,
mucopurulent anal discharge, rectal bleeding, and tenesmus.
The clinician performed a colonoscopy, which revealed
ulcerative proctitis with ulceration of the lower rectum. A
rectal biopsy was performed. Taken together, these ele-
ments supported a diagnosis of infectious proctitis. Micro-
scopic examination of a Gram-stained rectal biopsy smear
specimen revealed a high white blood cell count without dip-
lococci. The rectal biopsy sample was positive for C. tracho-
matis by real-time PCR (Arthus C. trachomatis PCR kit;
Qiagen, Courtaboeuf, France), and the diagnosis of LGV
proctitis was conﬁrmed by the detection of LGV biovar-spe-
ciﬁc DNA as previously recommended [3]. Genotyping and
sequencing of the ompA gene conducted at the French
National Reference Centre of Chlamydiae (Bordeaux,
France) showed that the LGV strain harboured an ompA
genotype identical to that of the C. trachomatis L2b/UCH-1/
proctitis reference strain [4]. By use of a multilocus
sequence typing (MLST) scheme, targeting ﬁve genes, we
determined that this LGV strain harboured the MLST
sequence type 58, which is speciﬁc for the epidemic C. tra-
chomatis L2b strain (http://mlstdb.bmc.uu.se) [5]. The patient
showed positive serology for C. trachomatis, with high anti-
body titres suggestive of LGV (IgG ratio of 5.4 and IgA ratio
of >7 for a 1.1 ratio positive threshold (Savyon Diagnostics,
Ashdod, Israel)) [6]. No other STI (HIV, hepatitis B virus,
hepatitis C virus, syphilis, or gonorrhoea) was diagnosed.
The patient has checked for her HIV status every 6 months.
She was treated with doxycycline for 3 weeks, which
resulted in recovery. The patient reported a sexually promis-
cuous lifestyle. She had a regular partner, her husband, with
whom she had unprotected sex. In addition, she reported
having 10–15 anonymous male or female sex partners per
month. She reported anal intercourse with an irregular part-
ner 1 week before symptoms appeared.
Until now, LGV has typically presented as severe proctitis
in HIV-positive men who have sex with men (MSM), and only
proctitis cases with non-LGV serovars or cervicitis with LGV
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(non-C. trachomatis L2b) serovars [1,3,7,8] have been reported
in women. Moreover, other concomitant STIs are often diag-
nosed in MSM with LGV. In contrast, in the case reported
here, the patient had no other STIs or HIV infection.
By sequencing the ompA gene, Spaargaren et al. [2] demon-
strated that C. trachomatis L2b was the strain causing the Euro-
pean LGV outbreak. The recent MLST genotyping scheme
developed for C. trachomatis has been used to investigate
genetic variation in LGV strains [5]. In this study, the 22 LGV
specimens obtained from MSM in the 1980s were separated
into three ompA genotypes and ﬁve MLST genotypes. In con-
trast, all 50 specimens obtained from Europe collected
between 2004 and 2009, including 15 French isolates, and the
ﬁve specimens collected from the USA between 2007 and
2009 shared an identical MLST sequence type (ST58). More-
over, all but one of these specimens had an ompA genotype
identical to that of the C. trachomatis L2b/UCH-1/proctitis ref-
erence strain. These ﬁndings suggest a single source of origin
for the LGV outbreak among MSM in Europe. By using the
MLST scheme described above, we found that our LGV speci-
men had an MLST proﬁle and an ompA genotype identical to
those of the European variant, suggesting that it belongs to the
same cluster as the outbreak variant.
Since the beginning of the LGV outbreak, only a few stud-
ies have been conducted on ompA genotypes of female rectal
specimens, especially from high-risk women (women who
had receptive anorectal intercourse or anorectal symptoms,
or who had contact with gonorrhoea). Recently, Setupathi
et al. [9] showed that, among 160 rectal swabs obtained
from such women, 12.5% (20/160) were positive for C. tra-
chomatis, and all of these isolates were of non-LGV serovars.
Geisler et al. [10] evaluated the distribution and the epidemi-
ology of rectal ompA genotypes in women in Birmingham
between 2003 and 2007. No LGV genotypes were detected
among the 33 C. trachomatis-positive rectal specimens found.
In a study conducted at Rotterdam between 2001 and 2005,
a total of 219 rectal C. trachomatis infections were diagnosed
[11]. In all, 156 (71.2%) were from male patients and 63
(28.8%) were from females. C. trachomatis L2 was identiﬁed
in 21 rectal specimens, all from men.
Occasional cases of heterosexually transmitted LGV have
been seen in Europe, but only cervicitis has been described
in women [7,8]. LGV was diagnosed in a heterosexual couple
in Spain [7]. The man presented with urethritis and the
women with cervicitis. It is important to note that C. tracho-
matis L2, but not C. trachomatis L2b, was detected in both
partners. Recently, Gomes et al. [8] reported LGV cases of
urethritis and cervicitis among heterosexual Portuguese
patients. Most of these patients were asymptomatic or pre-
sented no clear LGV symptoms. All C. trachomatis-positive
samples revealed ompA sequences that differed from the
C. trachomatis L2/434 reference strain and from the C. tracho-
matis L2b/14476 strain, which was the most frequently
described genotype in the recent LGV outbreak. In a study
conducted in France between 2004 and 2009, no LGV strain
was found among 2902 female urogenital samples screened
by an L serovar-speciﬁc real-time PCR assay [12,13].
As recommended by the current guidelines for LGV treat-
ment, our patient received 3 weeks of doxycycline [3]. A
complete response was observed to this therapy.
To our knowledge, this is the ﬁrst case reported of C. tra-
chomatis L2B proctitis in a heterosexual woman. Exclusion of
extragenital sites (rectal and oropharyngeal), which are not
commonly tested for STIs, can leave many infections undiag-
nosed. These justify clinical awareness and attentive surveil-
lance in all populations that are at risk for sexually acquired
C. trachomatis infections.
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